Sex-Based Disparities in the Transition to Dolutegravir-Based Antiretroviral Therapy in West African HIV Cohorts.

Authors :: Tiendrebeogo T
Malateste K
Poda A
Minga A
Messou E
Chenal H
Ezechi O
Ekouevi DK
Ofotokun I
Jaquet A
Source :: Open forum infectious diseases [Open Forum Infect Dis] 2024 Mar 19; Vol. 11 (5), pp. ofae139. Date of Electronic Publication: 2024 Mar 19 (Print Publication: 2024).
Publication Year :: 2024
Abstract: Transition to dolutegravir among 21 167 individuals experienced in antiretroviral therapy in West Africa showed heterogeneous timelines and patterns. Initially reported sex disparities tended to catch up over time with persisting disparities, according to contributing HIV clinics. Key factors facilitating dolutegravir switch were male sex, age <50 years, viral suppression, and regimens not based on protease inhibitors.<br /> (© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)

Full Text Access

Tools